Castellarnau, Alex
Heery, Graham P.
Seta, Aynaz
Luscombe, Carolyn A.
Kinghorn, George R.
Button, Peter
McCloud, Philip
Paull, Jeremy R. A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
https://doi.org/10.1038/s41598-022-14601-3
Funding for this research was provided by:
Starpharma Pty Ltd
Australian Medical Research Future Fund Biomedical Translation Bridge Program (BTBR300093)
Article History
Received: 28 February 2022
Accepted: 9 June 2022
First Online: 17 June 2022
Competing interests
: The authors JRAP, GPH and AS are paid employees of Starpharma Pty Ltd. The authors AC, CAL, GRK, PB and PMc are paid consultants to Starpharma Pty Ltd. JRAP, GPH, AS, AC and CAL are shareholders of Starpharma Holdings Ltd.